Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-583 in Postherpetic Neuralgia
NCT00377598Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of TAK-583 in postherpetic neuralgia (PHN), sponsored by Takeda. Started Oct 2006; status: completed.
02
Drugs
TAK-583
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00377598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377598.